Shin-Cheh Chen

9PUBLICATIONS
89CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)BiomaterialsPredictive and prognostic markersClinical midwifery
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 06, 2026
2025 Update of the Taiwan Expert Consensus on Hormone Receptor-Positive Metastatic Breast Cancer Management.

|May 26, 2026
Durvalumab plus Paclitaxel, with or without Capivasertib or Oleclumab, in Patients with Locally Advanced/Metastatic Triple-Negative Breast Cancer.

|Jan 08, 2026
DESTINY-Breast08: A Phase Ib Study of Trastuzumab Deruxtecan in Combination with Other Anticancer Therapies in Patients with HER2-Low Metastatic Breast Cancer.

Komal Jhaveri, Sherene Loi, Erika Hamilton

|Oct 28, 2025
Clinical Scenarios Using Thoracodorsal and Lateral Thoracic Vessels Versus Internal Mammary Vessels in Bipedicled Deep Inferior Epigastric Perforator Flap Breast Reconstruction: A Comparative Study.

Chia-Fang Chen, David Chon-Fok Cheong, Wen-Ling Kuo

|May 09, 2025
Capivasertib plus fulvestrant in patients with HR-positive/HER2-negative advanced breast cancer: phase 3 CAPItello-291 study extended Chinese cohort.

Xichun Hu, Qingyuan Zhang, Tao Sun

|Sep 23, 2022
Factors Associated with Axillary Lymph Node Status in Clinically Node-Negative Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy.

Chi-Chang Yu, Yun-Chung Cheung, Shir-Hwa Ueng

Pageof 2

Frequent Collaborators

4 joint publications

Chi-Chang Yu

4 joint publications

Yen-Shen Lu

3 joint publications

Wen-Ling Kuo

2 joint publications

Yun-Chung Cheung